These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1093 related articles for article (PubMed ID: 11833459)

  • 1. [Anchoring cytokines to cancer cells using diphtheria toxin: better than immunotherapy by gene transfer?].
    Nizard P; Gross DA; Chenal A; Beaumelle B; Kosmatopoulos K; Gillet D
    J Soc Biol; 2001; 195(3):229-34. PubMed ID: 11833459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycolipid-anchored IL-12 expressed on tumor cell surface induces antitumor immune response.
    Nagarajan S; Selvaraj P
    Cancer Res; 2002 May; 62(10):2869-74. PubMed ID: 12019166
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytokine, chemokine, and co-stimulatory fusion proteins for the immunotherapy of solid tumors.
    Khawli LA; Hu P; Epstein AL
    Handb Exp Pharmacol; 2008; (181):291-328. PubMed ID: 18071951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted therapy of cancer using diphtheria toxin-derived immunotoxins.
    Potala S; Sahoo SK; Verma RS
    Drug Discov Today; 2008 Sep; 13(17-18):807-15. PubMed ID: 18678276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Virotherapy clinical trials for regional disease: in situ immune modulation using recombinant poxvirus vectors.
    Mastrangelo MJ; Lattime EC
    Cancer Gene Ther; 2002 Dec; 9(12):1013-21. PubMed ID: 12522440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic therapeutic effects of a tumor targeting antibody fragment, fused to interleukin 12 and to tumor necrosis factor alpha.
    Halin C; Gafner V; Villani ME; Borsi L; Berndt A; Kosmehl H; Zardi L; Neri D
    Cancer Res; 2003 Jun; 63(12):3202-10. PubMed ID: 12810649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetically modified autoactivated cells expressing intracellular forms of GM-CSF as a model for regulated administration of cytokines.
    Arteaga HJ; Mohamed AJ; Christensson B; Mahdy E; Gahrton G; Smith CI; Dilber MS
    Scand J Immunol; 2005 Nov; 62(5):429-36. PubMed ID: 16305639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunological therapy of human tumors by gene-modified cellular vaccines.
    Parmiani G
    Folia Biol (Praha); 2000; 46(6):207-9. PubMed ID: 11140852
    [No Abstract]   [Full Text] [Related]  

  • 10. Antitumor effects of recombinant BCG and interleukin-12 DNA vaccines on xenografted murine bladder cancer.
    Yu DS; Lee CF; Hsieh DS; Chang SY
    Urology; 2004 Mar; 63(3):596-601. PubMed ID: 15028475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of cytokines to enhance vaccine effects of heat shock protein 70-rich tumor cell lysate.
    Ito A; Fujioka M; Tanaka K; Kobayashi T; Honda H
    J Biosci Bioeng; 2005 Jul; 100(1):36-42. PubMed ID: 16233848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creation of intercellular bonds by anchoring protein ligands to membranes using the diphtheria toxin T domain.
    Perier A; Gourier C; Pichard S; Husson J; Lajeunesse E; Babon A; Menez A; Gillet D
    FEBS Lett; 2007 Nov; 581(28):5480-4. PubMed ID: 17991440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted therapy to the IL-2R using diphtheria toxin and caspase-3 fusion proteins modulates Treg and ameliorates inflammatory colitis.
    Yarkoni S; Sagiv Y; Kaminitz A; Farkas DL; Askenasy N
    Eur J Immunol; 2009 Oct; 39(10):2850-64. PubMed ID: 19735074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multiprong approach to cancer gene therapy by coencapsulated cells.
    Cirone P; Shen F; Chang PL
    Cancer Gene Ther; 2005 Apr; 12(4):369-80. PubMed ID: 15692610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
    Urieto JO; Liu T; Black JH; Cohen KA; Hall PD; Willingham MC; Pennell LK; Hogge DE; Kreitman RJ; Frankel AE
    Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular strategies for improving cytokine transgene expression in normal and malignant tissues.
    Yang NS; Wang JH; Turner J
    Gene Ther; 2004 Jan; 11(1):100-8. PubMed ID: 14681703
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokine gene transfer in cancer therapy.
    Cao L; Kulmburg P; Veelken H; Mackensen A; Mézes B; Lindemann A; Mertelsmann R; Rosenthal FM
    Stem Cells; 1998; 16 Suppl 1():251-60. PubMed ID: 11012169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody-cytokine fusion proteins.
    Kontermann RE
    Arch Biochem Biophys; 2012 Oct; 526(2):194-205. PubMed ID: 22445675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinational adenovirus-mediated gene therapy and dendritic cell vaccine in combating well-established tumors.
    Xia D; Moyana T; Xiang J
    Cell Res; 2006 Mar; 16(3):241-59. PubMed ID: 16541123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune responses to human tumors: development of tumor vaccines.
    Platsoucas CD; Fincke JE; Pappas J; Jung WJ; Heckel M; Schwarting R; Magira E; Monos D; Freedman RS
    Anticancer Res; 2003; 23(3A):1969-96. PubMed ID: 12894571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.